{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:02:08Z","timestamp":1784768528368,"version":"3.55.0"},"reference-count":56,"publisher":"American Association for Laboratory Animal Science","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Anesthesia-induced lens opacity has been reported in rats and mice and is characterized as acute and reversible. In ophthalmologic research, lens opacity often interferes with the accurate acquisition of ocular data. In this study, we investigated the usefulness of alfaxalone, an anesthetic known for its favorable safety profile, for prevention of anesthesia-induced lens opacity in rats. First, anesthetic protocols using alfaxalone were screened to identify those suitable for the study. Then, the induction profiles of transient lens opacity following intraperitoneal administration of alfaxalone\u2013butorphanol and alfaxalone\u2013midazolam\u2013butorphanol were evaluated, and the findings were compared with those obtained for ketamine\u2013xylazine, which is known to induce lens opacity. Lens opacity induced by alfaxalone-based anesthetic combinations was significantly milder than that induced by ketamine\u2013xylazine. Alfaxalone-based anesthetic combinations suppressed reflex responses, and alfaxalone\u2013midazolam\u2013butorphanol provided sufficient depth and duration of anesthesia for morphology-based assessment of the eye, although the depth of anesthesia was lower than that achieved with ketamine\u2013xylazine. In conclusion, the combination of alfaxalone, midazolam, and butorphanol may represent a promising anesthetic option for ophthalmologic studies in rats.<\/jats:p>","DOI":"10.30802\/aalas-jaalas-26-013","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:30:49Z","timestamp":1781742649000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Alfaxalone-Based Anesthetic Combinations to Minimize Anesthesia-Induced Transient Lens Opacity in Rats (Rattus norvegicus)"],"prefix":"10.30802","author":[{"given":"Atsuko","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Pharmacology Research, Discovery Research Division, Senju Pharmaceutical Co, Ltd, Kobe, Hyogo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Yamagiwa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Department, Research and Development Division, Senju Pharmaceutical Co, Ltd, Kobe, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"The Principles of Humane Experimental Technique.","author":"Russell WMS","year":"1959","unstructured":"Russell WMS, Burch RL. The Principles of Humane Experimental Technique. Methuen and Co; 1959 (Reissued: Universities Federation for Animal Welfare; 1992)."},{"key":"bib2","series-title":"Anesthesia and Analgesia in Laboratory Animals.","first-page":"239","article-title":"Chapter 10 \u2013 anesthesia and analgesia for laboratory rodents","author":"Gaetner DJ","year":"2008","unstructured":"Gaetner DJ, Hallman TM, Hankenson FC, Batchelder MA. Chapter 10 \u2013 anesthesia and analgesia for laboratory rodents. In: Fish RE, Danneman PJ, Brown MJ, Karas AZ, editors. Anesthesia and Analgesia in Laboratory Animals. 2nd ed. Academic Press; 2008:239\u2013297."},{"key":"bib3","series-title":"Laboratory Animal Anesthesia and Analgesia.","first-page":"215","article-title":"Chapter 6 \u2013 anaesthesia of common laboratory species: special considerations","author":"Flecknell P","year":"2023","unstructured":"Flecknell P. Chapter 6 \u2013 anaesthesia of common laboratory species: special considerations. In: Laboratory Animal Anesthesia and Analgesia. 5th ed. Academic Press; 2023:215\u2013282."},{"key":"bib4","series-title":"Exp Anim.","first-page":"329","article-title":"The validity of anesthetic protocols for the surgical procedure of castration in rats","volume":"67","author":"Tukamoto A","year":"2018","unstructured":"Tukamoto A, Niino N, Sakamoto M, Ohtani R, Inomata T. The validity of anesthetic protocols for the surgical procedure of castration in rats. Exp Anim. 2018;67:329\u2013336."},{"issue":"3","key":"bib5","series-title":"Lab Anim.","first-page":"179","article-title":"The effects of pentobarbital, ketamine\u2013pentobarbital and ketamine\u2013xylazine anesthesia in a rat myocardial ischemic reperfusion injury model","volume":"50","author":"Shekarforoush S","year":"2016","unstructured":"Shekarforoush S, Fatahi Z, Safari F. The effects of pentobarbital, ketamine\u2013pentobarbital and ketamine\u2013xylazine anesthesia in a rat myocardial ischemic reperfusion injury model. Lab Anim. 2016;50(3):179\u2013184."},{"issue":"2","key":"bib6","series-title":"J Vet Med Sci.","first-page":"387","article-title":"Blood biochemistry and hematological changes in rats after administration of a mixture of three anesthetic agents","volume":"80","author":"Ochiai Y","year":"2018","unstructured":"Ochiai Y, Baba A, Hiramatsu M, et al. Blood biochemistry and hematological changes in rats after administration of a mixture of three anesthetic agents. J Vet Med Sci. 2018;80(2):387\u2013394."},{"issue":"1","key":"bib7","series-title":"J Vet Med Sci.","first-page":"35","article-title":"Comparison of the anesthetic effect by the injection route of mixed anesthesia (medetomidine, midazolam and butorphanol) and the effect of this anesthetic agent on the respiratory function","volume":"82","author":"Shibuta H","year":"2020","unstructured":"Shibuta H, Yamana R, Kashimoto J, Kamino K, Suda A. Comparison of the anesthetic effect by the injection route of mixed anesthesia (medetomidine, midazolam and butorphanol) and the effect of this anesthetic agent on the respiratory function. J Vet Med Sci. 2020;82(1):35\u201342."},{"issue":"4","key":"bib8","series-title":"Exp Eye Res.","first-page":"331","article-title":"Acute reversible cataract induced by xylazine and by ketamine\u2013xylazine anesthesia in rats and mice","volume":"42","author":"Calderone L","year":"1986","unstructured":"Calderone L, Grimes P, Shalev M. Acute reversible cataract induced by xylazine and by ketamine\u2013xylazine anesthesia in rats and mice. Exp Eye Res. 1986;42(4):331\u2013337."},{"issue":"1","key":"bib9","series-title":"J Neurosci Methods.","first-page":"67","article-title":"Ketamine-xylazine anesthesia causes hyperopic refractive shift in mice","volume":"193","author":"Tkatchenko TV","year":"2010","unstructured":"Tkatchenko TV, Tkatchenko AV. Ketamine-xylazine anesthesia causes hyperopic refractive shift in mice. J Neurosci Methods. 2010;193(1):67\u201371."},{"key":"bib10","series-title":"Lab Anim Res.","first-page":"1","article-title":"Evaluation of factors related to anaesthesia-induced lens opacity in experimental mice","volume":"36","author":"Lee H","year":"2020","unstructured":"Lee H, Kim HK, Shin HS, et al. Evaluation of factors related to anaesthesia-induced lens opacity in experimental mice. Lab Anim Res. 2020;36:1."},{"issue":"2","key":"bib11","series-title":"J Chromatogr B Biomed Sci Appl.","first-page":"357","article-title":"High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats","volume":"745","author":"Visser SA","year":"2000","unstructured":"Visser SA, Smulders CJ, Gladdines WW, Irth H, van der Graaf PH, Danhof M. High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats. J Chromatogr B Biomed Sci Appl. 2000;745(2):357\u2013363."},{"issue":"6","key":"bib12","series-title":"Lab Anim.","first-page":"588","article-title":"Anaesthetic effects of alfaxalone administered intraperitoneally alone or combined with dexmedetomidine and fentanyl in the rat","volume":"52","author":"Arenillas M","year":"2018","unstructured":"Arenillas M, Gomez de Segura IA. Anaesthetic effects of alfaxalone administered intraperitoneally alone or combined with dexmedetomidine and fentanyl in the rat. Lab Anim. 2018;52(6):588\u2013598."},{"issue":"5","key":"bib13","series-title":"J Am Assoc Lab Anim Sci.","first-page":"531","article-title":"Intraperitoneal alfaxalone and alfaxalone-dexmedetomidine anesthesia in Sprague-Dawley rats (Rattus norvegicus)","volume":"59","author":"West SE","year":"2020","unstructured":"West SE, Lee JC, Johns TN, Nunamaker EA. Intraperitoneal alfaxalone and alfaxalone-dexmedetomidine anesthesia in Sprague-Dawley rats (Rattus norvegicus). J Am Assoc Lab Anim Sci. 2020;59(5):531\u2013538."},{"issue":"1","key":"bib14","series-title":"J Am Assoc Lab Anim Sci.","first-page":"30","article-title":"Alfaxalone\u2013xylazine anesthesia in laboratory mice (Mus musculus)","volume":"58","author":"Erickson RL","year":"2019","unstructured":"Erickson RL, Blevins CE, de Souza Dyer C, Marx JO. Alfaxalone\u2013xylazine anesthesia in laboratory mice (Mus musculus). J Am Assoc Lab Anim Sci. 2019;58(1):30\u201339."},{"issue":"5","key":"bib15","series-title":"J Am Assoc Lab Anim Sci.","first-page":"475","article-title":"Intramuscular alfaxalone\u2013butorphanol\u2013midazolam compared with ketamine\u2013butorphanol\u2013midazolam in New Zealand White rabbits","volume":"61","author":"Knutson KA","year":"2022","unstructured":"Knutson KA, Petritz OA, Thomson AE, Balko JA. Intramuscular alfaxalone\u2013butorphanol\u2013midazolam compared with ketamine\u2013butorphanol\u2013midazolam in New Zealand White rabbits. J Am Assoc Lab Anim Sci. 2022;61(5):475\u2013481."},{"issue":"5","key":"bib16","series-title":"J Am Assoc Lab Anim Sci.","first-page":"539","article-title":"Anesthetic effects of intramuscular alfaxalone\u2013ketamine in naked mole rats (Heterocephalus glaber)","volume":"59","author":"Ambar N","year":"2020","unstructured":"Ambar N, Eshar D, Shrader TC, Beaufr\u00e8re H. Anesthetic effects of intramuscular alfaxalone\u2013ketamine in naked mole rats (Heterocephalus glaber). J Am Assoc Lab Anim Sci. 2020;59(5):539\u2013545."},{"key":"bib17","series-title":"J Am Assoc Lab Anim Sci.","first-page":"384","article-title":"Anesthetic effects of alfaxalone\u2013ketamine, alfaxalone\u2013ketamine\u2013dexmedetomidine, and alfaxalone\u2013butorphanol\u2013midazolam administered intramuscularly in five-striped palm squirrels (Funambulus pennantii)","volume":"59","author":"Eshar D","year":"2020","unstructured":"Eshar D, Beaufr\u00e8re H. Anesthetic effects of alfaxalone\u2013ketamine, alfaxalone\u2013ketamine\u2013dexmedetomidine, and alfaxalone\u2013butorphanol\u2013midazolam administered intramuscularly in five-striped palm squirrels (Funambulus pennantii). J Am Assoc Lab Anim Sci. 2020;59:384\u2013392."},{"key":"bib18","series-title":"Invest Ophthalmol Vis Sci.","first-page":"5653","article-title":"Comparison between injectable anesthetic agents on transient cataract induced by general anesthesia in rats","volume":"59","author":"Yamashita A","year":"2018","unstructured":"Yamashita A, Sakai O, Tokushige H. Comparison between injectable anesthetic agents on transient cataract induced by general anesthesia in rats. Invest Ophthalmol Vis Sci. 2018;59:5653."},{"key":"bib19","series-title":"Laboratory Animal Anesthesia and Analgesia.","first-page":"51","article-title":"Chapter 2 \u2013 anaesthetic and analgesic agents","author":"Flecknell P","year":"2023","unstructured":"Flecknell P. Chapter 2 \u2013 anaesthetic and analgesic agents. In: Laboratory Animal Anesthesia and Analgesia. 5th ed. Academic Press; 2023:51\u201390."},{"issue":"4","key":"bib20","series-title":"Vet Anaesth Analg.","first-page":"229","article-title":"Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of alfaxan-CD RTU","volume":"33","author":"Ferr\u00e9 PJ","year":"2006","unstructured":"Ferr\u00e9 PJ, Pasloske K, Whittem T, Ranasinghe MG, Li Q, Lefebvre HP. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of alfaxan-CD RTU. Vet Anaesth Analg. 2006;33(4):229\u2013236."},{"issue":"2","key":"bib21","series-title":"Jpn J Vet Res.","first-page":"131","article-title":"Evaluation of a combination of alfaxalone with medetomidine and butorphanol for inducing surgical anesthesia in laboratory mice","volume":"64","author":"Higuchi S","year":"2016","unstructured":"Higuchi S, Yamada R, Hashimoto A, Miyoshi K, Yamashita K, Ohsugi T. Evaluation of a combination of alfaxalone with medetomidine and butorphanol for inducing surgical anesthesia in laboratory mice. Jpn J Vet Res. 2016;64(2):131\u2013139."},{"issue":"3","key":"bib22","series-title":"Vet Anaesth Analg.","first-page":"275","article-title":"Comparison of pain on injection during induction of anaesthesia with alfaxalone and two formulations of propofol in dogs","volume":"39","author":"Michou JN","year":"2012","unstructured":"Michou JN, Leece EA, Brearley JC. Comparison of pain on injection during induction of anaesthesia with alfaxalone and two formulations of propofol in dogs. Vet Anaesth Analg. 2012;39(3):275\u2013281."},{"issue":"6","key":"bib23","series-title":"Vet Anaesth Analg.","first-page":"451","article-title":"Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs","volume":"35","author":"Muir W","year":"2008","unstructured":"Muir W, Lerche P, Wiese A, Nelson L, Pasloske K, Whittem T. Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs. Vet Anaesth Analg. 2008;35(6):451\u2013462."},{"issue":"3","key":"bib24","series-title":"J Am Assoc Lab Anim Sci.","first-page":"686","article-title":"Anesthetic and postanesthetic effects of alfaxalone\u2013butorphanol compared with dexmedetomidine\u2013ketamine in Chinchillas (Chinchilla lanigera)","volume":"56","author":"Levy DR","year":"2017","unstructured":"Levy DR, Flores R, Garcia GE, Craig SL, Jensen VB. Anesthetic and postanesthetic effects of alfaxalone\u2013butorphanol compared with dexmedetomidine\u2013ketamine in Chinchillas (Chinchilla lanigera). J Am Assoc Lab Anim Sci. 2017;56(3):686\u2013694."},{"key":"bib25","series-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press; 2011."},{"issue":"6","key":"bib26","series-title":"Pharmacol Res Perspect.","first-page":"e01031","article-title":"Alfaxalone population pharmacokinetics in the rat: model application for pharmacokinetic and pharmacodynamic design in inbred and outbred strains and sexes","volume":"10","author":"White K","year":"2022","unstructured":"White K, Aldurdunji M, Harris J, Ortori C, Paine S. Alfaxalone population pharmacokinetics in the rat: model application for pharmacokinetic and pharmacodynamic design in inbred and outbred strains and sexes. Pharmacol Res Perspect. 2022;10(6):e01031."},{"key":"bib27","series-title":"J Am Assoc Lab Anim Sci.","first-page":"567","article-title":"Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats","volume":"52","author":"Veilleux-Lemieux D","year":"2013","unstructured":"Veilleux-Lemieux D, Castel A, Carrier D, Beaudry F, Vachon P. Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats. J Am Assoc Lab Anim Sci. 2013;52:567\u2013570."},{"issue":"3","key":"bib28","series-title":"Psychopharmacology (Berl).","first-page":"241","article-title":"Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics","volume":"126","author":"Lau CE","year":"1996","unstructured":"Lau CE, Ma F, Wang Y, Smith C. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics. Psychopharmacology (Berl). 1996;126(3):241\u2013248."},{"issue":"1-2","key":"bib29","series-title":"J Chromatogr B Analyt Technol Biomed Life Sci.","first-page":"230","article-title":"High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic\/pharmacodynamic studies in rats","volume":"822","author":"Groenendaal G","year":"2005","unstructured":"Groenendaal G, Blom-Roosemalen MCM, Danhof M, de Lange ECM. High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic\/pharmacodynamic studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;822(1-2):230\u2013237."},{"issue":"3","key":"bib30","series-title":"Exp Anim.","first-page":"173","article-title":"Anesthetic effects of a mixture of medetomidine, midazolam and butorphanol in two strains of mice","volume":"62","author":"Kirihara Y","year":"2013","unstructured":"Kirihara Y, Takechi M, Kurosaki K, Kobayashi Y, Kurosawa T. Anesthetic effects of a mixture of medetomidine, midazolam and butorphanol in two strains of mice. Exp Anim. 2013;62(3):173\u2013180."},{"issue":"5","key":"bib31","series-title":"Vet Anaesth Analg.","first-page":"609","article-title":"Effects of midazolam before or after alfaxalone for co-induction of anaesthesia in healthy dogs","volume":"45","author":"Zapata A","year":"2018","unstructured":"Zapata A, Laredo FG, Escobar M, Agut A, Soler M, Belda E. Effects of midazolam before or after alfaxalone for co-induction of anaesthesia in healthy dogs. Vet Anaesth Analg. 2018;45(5):609\u2013617."},{"issue":"6","key":"bib32","series-title":"J Vet Med Sci.","first-page":"929","article-title":"The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs","volume":"78","author":"Tamura J","year":"2016","unstructured":"Tamura J, Hatakeyama N, Ishizuka T, et al. The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs. J Vet Med Sci. 2016;78(6):929\u2013936."},{"issue":"1","key":"bib33","series-title":"CNS Drugs.","first-page":"39","article-title":"The role of GABA receptors in anesthesia and sedation: an updated review","volume":"39","author":"Philip AB","year":"2025","unstructured":"Philip AB, Brohan J, Goudra B. The role of GABA receptors in anesthesia and sedation: an updated review. CNS Drugs. 2025;39(1):39\u201354."},{"issue":"9","key":"bib34","series-title":"Yakugaku Zasshi.","first-page":"713","article-title":"Elucidation of the mechanisms underlying the rapid antidepressant actions of ketamine and search for possible candidates for novel rapid-acting antidepressants","volume":"143","author":"Deyama S","year":"2023","unstructured":"Deyama S. Elucidation of the mechanisms underlying the rapid antidepressant actions of ketamine and search for possible candidates for novel rapid-acting antidepressants. Yakugaku Zasshi. 2023;143(9):713\u2013720."},{"issue":"1","key":"bib35","series-title":"Lab Anim.","first-page":"1","article-title":"Refining procedures for the administration of substances. Report of the BVAAWF\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation\/Fund for the Replacement of Animals in Medical Experiments\/Royal Society for the Prevention of Cruelty to Animals\/Universities Federation for Animal Welfare","volume":"35","author":"Morton DB","year":"2001","unstructured":"Morton DB, Jennings M, Buckwell A, et al. Refining procedures for the administration of substances. Report of the BVAAWF\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation\/Fund for the Replacement of Animals in Medical Experiments\/Royal Society for the Prevention of Cruelty to Animals\/Universities Federation for Animal Welfare. Lab Anim. 2001;35(1):1\u201341."},{"issue":"2","key":"bib36","series-title":"Int J Toxicol.","first-page":"95","article-title":"Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility","volume":"35","author":"Gad SC","year":"2016","unstructured":"Gad SC, Spainhour CB, Shoemake C, et al. Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility. Int J Toxicol. 2016;35(2):95\u2013178."},{"key":"bib37","series-title":"Carbohydr Polym.","first-page":"119880","article-title":"Integration of cyclodextrins and associated toxicities: a roadmap for high quality biomedical applications","volume":"295","author":"Trotta F","year":"2022","unstructured":"Trotta F, Loftsson T, Gaud RS, Trivedi R, Shende P. Integration of cyclodextrins and associated toxicities: a roadmap for high quality biomedical applications. Carbohydr Polym. 2022;295:119880."},{"key":"bib38","series-title":"Invest Ophthalmol Vis Sci.","first-page":"461","article-title":"Preventing corneal calcification associated with xylazine for longitudinal optical coherence tomography in young rodents","volume":"58","author":"Zou TE","year":"2017","unstructured":"Zou TE, Sayah DN, Noueihed B, et al. Preventing corneal calcification associated with xylazine for longitudinal optical coherence tomography in young rodents. Invest Ophthalmol Vis Sci. 2017;58:461\u2013469."},{"issue":"12","key":"bib39","series-title":"J Toxicol Sci.","first-page":"561","article-title":"Corneal lesions related to an anesthetic mixture of medetomidine, midazolam, and butorphanol treatment in rats","volume":"46","author":"Kamio K","year":"2021","unstructured":"Kamio K, Morita J, Nakanishi Y, Sasaki M, Wakamatsu M. Corneal lesions related to an anesthetic mixture of medetomidine, midazolam, and butorphanol treatment in rats. J Toxicol Sci. 2021;46(12):561\u2013568."},{"issue":"7","key":"bib40","series-title":"Int J Mol Sci.","first-page":"3748","article-title":"Aquaporins in the cornea","volume":"25","author":"Melnyk S","year":"2024","unstructured":"Melnyk S, Bollag WB. Aquaporins in the cornea. Int J Mol Sci. 2024;25(7):3748."},{"issue":"7","key":"bib41","series-title":"Curr Eye Res.","first-page":"943","article-title":"Topical use of NaCl solution with different concentration affects lens transparency in anesthetized mice","volume":"41","author":"Gu Y","year":"2016","unstructured":"Gu Y, Xu B, Feng C, et al. Topical use of NaCl solution with different concentration affects lens transparency in anesthetized mice. Curr Eye Res. 2016;41(7):943\u2013950."},{"issue":"1","key":"bib42","series-title":"Exp Eye Res.","first-page":"19","article-title":"Acute reversible lens opacity: caused by drugs, cold, anoxia, asphyxia, stress, death and dehydration","volume":"10","author":"Fraunfelder FT","year":"1970","unstructured":"Fraunfelder FT, Burns RP. Acute reversible lens opacity: caused by drugs, cold, anoxia, asphyxia, stress, death and dehydration. Exp Eye Res. 1970;10(1):19\u201330."},{"key":"bib43","series-title":"J Ophthalmol.","first-page":"568509","article-title":"Assessment of full-eye response to osmotic stress in mouse model in vivo using optical coherence tomography","volume":"2015","author":"Ni Y","year":"2015","unstructured":"Ni Y, Xu B, Wu L, et al. Assessment of full-eye response to osmotic stress in mouse model in vivo using optical coherence tomography. J Ophthalmol. 2015;2015:568509."},{"key":"bib44","series-title":"J Vis Exp.","first-page":"e66036","article-title":"A rat dry eye model with lacrimal gland dysfunction induced by scopolamine","volume":"204","author":"Li S","year":"2024","unstructured":"Li S, Xiao Y, Tang Y, et al. A rat dry eye model with lacrimal gland dysfunction induced by scopolamine. J Vis Exp. 2024;204:e66036."},{"issue":"6","key":"bib45","series-title":"Invest Ophthalmol Vis Sci.","first-page":"3234","article-title":"Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways","volume":"53","author":"Zagon IS","year":"2012","unstructured":"Zagon IS, Campbell AM, Sassani JW, McLaughlin PJ. Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways. Invest Ophthalmol Vis Sci. 2012;53(6):3234\u20133240."},{"issue":"6","key":"bib46","series-title":"Int J Ophthalmol.","first-page":"904","article-title":"Acute lens opacity induced by different kinds of anesthetic drugs in mice","volume":"12","author":"Li XT","year":"2019","unstructured":"Li XT, Qin Y, Zhao JY, Zhang JS. Acute lens opacity induced by different kinds of anesthetic drugs in mice. Int J Ophthalmol. 2019;12(6):904\u2013908."},{"issue":"3","key":"bib47","series-title":"Exp Eye Res.","first-page":"365","article-title":"Causes of cataract development in anesthetized mice","volume":"75","author":"Ridder W","year":"2002","unstructured":"Ridder W, Nusinowitz S, Heckenlively JR. Causes of cataract development in anesthetized mice. Exp Eye Res. 2002;75(3):365\u2013370."},{"issue":"11","key":"bib48","series-title":"J R Soc Med.","first-page":"694","article-title":"Phenylephrine-induced reversible cataract in the mouse","volume":"80","author":"Claou\u00e9 CM","year":"1987","unstructured":"Claou\u00e9 CM. Phenylephrine-induced reversible cataract in the mouse. J R Soc Med. 1987;80(11):694\u2013695."},{"issue":"2","key":"bib49","series-title":"Vet Sci.","first-page":"42","article-title":"Effect of intramuscular medetomidine administration on tear flow in rats","volume":"7","author":"Kanda T","year":"2020","unstructured":"Kanda T, Mizoguchi Y, Furumoto K, Shimizu Y, Maeta N, Furukawa T. Effect of intramuscular medetomidine administration on tear flow in rats. Vet Sci. 2020;7(2):42."},{"issue":"8","key":"bib50","series-title":"J Feline Med Surg.","first-page":"788","article-title":"Effect of intramuscular administration of medetomidine and xylazine on tear flow measured by the Schirmer tear test I in healthy cats","volume":"21","author":"Kanda T","year":"2019","unstructured":"Kanda T, Shimizu Y, Hanazono C, et al. Effect of intramuscular administration of medetomidine and xylazine on tear flow measured by the Schirmer tear test I in healthy cats. J Feline Med Surg. 2019;21(8):788\u2013792."},{"issue":"2","key":"bib51","series-title":"Vet Sci.","first-page":"28","article-title":"Dexmedetomidine and tear production: evaluation in dogs as spontaneous model for ocular surface disorders","volume":"8","author":"Pietro SD","year":"2021","unstructured":"Pietro SD, Giannetto C, Falcone A, et al. Dexmedetomidine and tear production: evaluation in dogs as spontaneous model for ocular surface disorders. Vet Sci. 2021;8(2):28."},{"key":"bib52","series-title":"The 37th Annual Meeting of the Japanese Society of Toxicology","first-page":"P150","article-title":"Acute reversible lens opacity induced by ketamine-xylazine anesthesia in rats","author":"Sugiyama M","year":"2010","unstructured":"Sugiyama M, Esaki T, Kobayashi M, et al. Acute reversible lens opacity induced by ketamine-xylazine anesthesia in rats. In: The 37th Annual Meeting of the Japanese Society of Toxicology. Japanese Society of Toxicology; 2010:P150."},{"issue":"1","key":"bib53","series-title":"Vet Ophthalmol.","first-page":"57","article-title":"Effects of intramuscular sedative and opioid combinations on tear production in dogs","volume":"1","author":"Dodam JR","year":"1998","unstructured":"Dodam JR, Branson KR, Martin DD. Effects of intramuscular sedative and opioid combinations on tear production in dogs. Vet Ophthalmol. 1998;1(1):57\u201359."},{"issue":"S11","key":"bib54","series-title":"Equine Vet. Educ.","first-page":"53","article-title":"Effects of intravenous romifidine, detomidine, detomidine combined with butorphanol, and xylazine on tear production in horses","volume":"32","author":"Leonardi F","year":"2020","unstructured":"Leonardi F, Costa GL, Dubau M, Sabbioni A, Simonazzi B, Angelone M. Effects of intravenous romifidine, detomidine, detomidine combined with butorphanol, and xylazine on tear production in horses. Equine Vet. Educ. 2020;32(S11):53\u201357."},{"key":"bib55","series-title":"Hear Res.","first-page":"108073","article-title":"Hydroxypropyl-\u03b2-cyclodextrin causes massive damage to the developing auditory and vestibular system","volume":"396","author":"Ding D","year":"2020","unstructured":"Ding D, Manohar S, Jiang H, Salvi R. Hydroxypropyl-\u03b2-cyclodextrin causes massive damage to the developing auditory and vestibular system. Hear Res. 2020;396:108073."},{"issue":"12","key":"bib56","series-title":"PLoS One.","first-page":"e53280","article-title":"Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-\u03b2-cyclodextrin","volume":"7","author":"Crumling MA","year":"2012","unstructured":"Crumling MA, Liu L, Thomas PV, et al. Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-\u03b2-cyclodextrin. PLoS One. 2012;7(12):e53280."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-013\/article-10.30802-AALAS-JAALAS-26-013.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-013\/article-10.30802-AALAS-JAALAS-26-013.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-013\/article-10.30802-AALAS-JAALAS-26-013.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:30:31Z","timestamp":1784766631000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-013\/article-10.30802-AALAS-JAALAS-26-013.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":56,"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-26-013","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}